Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $341.00, but opened at $310.00. Bio-Rad Laboratories shares last traded at $310.00, with a volume of 104 shares changing hands.
Bio-Rad Laboratories Stock Performance
The firm has a market cap of $9.77 billion, a PE ratio of -12.77 and a beta of 0.72. The stock has a 50-day moving average price of $333.49 and a 200 day moving average price of $325.90. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Read More
- Five stocks we like better than Bio-Rad Laboratories
- Why Invest in 5G? How to Invest in 5G Stocks
- SAP’s Strong Momentum: A Bullish Setup for Investors
- What is a Special Dividend?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How to Find Undervalued Stocks
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
